To synthesize recent evidence supporting NF-κB as a pivotal integrative signaling node in osteoarthritis (OA) and to explore its role in joint degeneration.
Key Findings:
NF-κB serves as an integrative signaling node linking mechanical stress, innate immune sensing, and metabolic inflammation in OA.
Mechanism-based stratification and network-oriented combination strategies may enhance precision treatment in OA.
Interpretation:
NF-κB activation in OA is influenced by various upstream stimuli and has compartment-specific effects on joint tissues, contributing to the disease's complexity.
Limitations:
The review does not provide specific clinical trial data or outcomes related to NF-κB-targeted therapies.
Further research is needed to fully elucidate the context-dependent nature of NF-κB signaling in OA.
Conclusion:
Positioning NF-κB as a hub of signaling integration offers a framework for understanding OA pathogenesis and suggests new directions for precision interventions.
So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.
In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.
